Depressive Disorders - Australia & Oceania

Australia & Oceania

Revenue in the Depressive Disorders market is projected to reach US$0.48bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 2.02%, resulting in a market volume of US$0.52bn by 2028.
In global comparison, most revenue will be generated in the United States (US$6,263.00m in 2024).
In relation to total population figures, per person revenues of US$200.30 are generated in 2024.

Key regions: Japan, United Kingdom, China, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Depressive Disorders market in Australia & Oceania is experiencing steady growth due to several factors. Customer preferences for effective and accessible treatment options, along with increasing awareness and understanding of mental health issues, are driving the demand for products and services in this market. Additionally, local special circumstances and underlying macroeconomic factors are also contributing to the development of the Depressive Disorders market in this region.Customer preferences in Australia & Oceania are focused on finding effective and accessible treatment options for depressive disorders. Customers are increasingly seeking out evidence-based therapies and medications that have been proven to be effective in managing depression. They are also looking for convenient and affordable options that can be accessed easily, such as online therapy platforms and telemedicine services. This preference for accessible and effective treatment options is driving the growth of the Depressive Disorders market in this region.Trends in the market show a growing awareness and understanding of mental health issues in Australia & Oceania. There is a greater recognition of the impact that depression can have on individuals and society as a whole. This increased awareness has led to a greater demand for mental health services and products, including therapy, counseling, and medication. The stigma surrounding mental health is also gradually decreasing, which is encouraging more individuals to seek help and treatment for their depressive disorders.Local special circumstances in Australia & Oceania also contribute to the development of the Depressive Disorders market. The region has a high prevalence of mental health issues, including depression, which creates a significant market demand. Additionally, the healthcare systems in these countries are well-developed, with a focus on providing comprehensive mental health services. This enables individuals with depressive disorders to access the necessary treatments and support.Underlying macroeconomic factors, such as the overall economic growth and healthcare expenditure in Australia & Oceania, also play a role in the development of the Depressive Disorders market. As the economies in this region continue to grow, individuals have more disposable income to spend on healthcare, including mental health services. The governments in these countries are also investing in mental health initiatives and programs, further driving the growth of the market.In conclusion, the Depressive Disorders market in Australia & Oceania is developing due to customer preferences for effective and accessible treatment options, increasing awareness and understanding of mental health issues, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing as more individuals seek help for their depressive disorders and as governments and healthcare systems invest in mental health initiatives.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.